Warren Huff Founding Chief Executive Officer and President
Warren is the Chairman, Chief Executive Officer and President of Reata Pharmaceuticals. He has served as our sole CEO, President, and as Chairman of the Board of Directors since our founding in 2002. Prior to founding Reata, Warren served as CEO in a number of health care and information technology start-up enterprises. Warren started his career as an attorney with Johnson & Gibbs, P.C., where he was a partner and Chairman of the Corporate Securities Practice. He received a B.B.A. magna cum laude from the University of Texas at Austin and a J.D. from Southern Methodist University Dedman School of Law.
James Bass Trinity Summits, LLC
James has served as a member of the Board of Directors since July 2004. James is a member of the Board of Managers of Snowbird Holdings, LLC and Trinity Summits, LLC. For the past five years, he has been managing family assets and investments as his primary business activity. He previously served as an executive director of FB Gemini Limited, an Asian regional investment bank based in Hong Kong, prior to which he was an associate attorney and later partner at Gibson, Dunn & Crutcher LLP. He graduated with a B.A. degree from Yale University and obtained his J.D. degree from Stanford University.
William D. McClellan, Jr. Aerin Medical Inc.
William has served as a member of the Board of Directors since March 2017. He is Chief Financial Officer of Aerin Medical Inc. since January 2018 and is also a financial management consultant to healthcare and life sciences companies. From June 2004 until June 2016, William was the Chief Financial Officer and Executive Vice President, Finance at On-X Life Technologies Holdings, Inc. Prior to June 2004, he held financial and accounting positions at various healthcare and other companies and was a certified public accountant serving as an auditor with Price Waterhouse Coopers for nine years. William currently serves on the board of directors of Apollo Endosurgery, Inc., a publicly-traded company, and chairs its audit committee. He received a B.B.A. in accounting from Abilene Christian University and is a Certified Public Accountant.
R. Kent McGaughy, Jr. CPMG, Inc.
Kent has served as a member of the Board of Directors since December 2004. He is a partner in CPMG, Inc. Prior to joining CPMG’s predecessor, Cardinal Investment Company, Inc. in 1997, he worked in mergers and acquisitions at Simmons & Company International. He currently serves on the boards of Apollo Endosurgery, Inc., a publicly-traded company, and several private companies. Kent received his B.A. from The University of Texas (summa cum laude and member of Phi Beta Kappa) and his M.B.A. from Harvard Business School.
Jack B. Nielsen Vivo Capital, LLC
Jack has served as a member of the Board of Directors since June 2006. He is a consultant to Vivo Capital, LLC, a healthcare focused investment firm. Prior to March 1, 2017, Jack worked within the Novo A/S organization and its venture activities since 2001 in several roles, most recently being employed as a Senior Partner based in Copenhagen, Denmark. From 2006 to 2012, Jack was employed as a Partner at Novo Ventures (US) Inc. in San Francisco, where he established the office which provides certain consultancy services to Novo A/S. He served on the board of directors of publicly-traded company Akebia Therapeutics, Inc. from 2013 to June 2015 and currently serves on the board of directors of publicly-traded companies Merus, B.V and Apollo Endosurgery, Inc. He is also currently a member of the board of directors of a number of private companies. Jack received a M.Sc. in Chemical Engineering from the Technical University in Denmark, and a Masters in Management of Technology from Center for Technology, Economics and Management; Technical University of Denmark.
William E. Rose Montrose Capital, Inc.
William has served as a member of the Board of Directors since February 2016. He is the President of Montrose Capital, Inc. Prior to Montrose, William was associated with HBK Capital Management from 1991 until 2012, serving in various capacities, including Co-Chief Investment Officer. He currently serves as the Chairman of the Board of Trustees for Greenhill School and is also a member of the Investment Committee for the Dallas Museum of Art. William received a B.A. in Political Science from Duke University in 1989.